The critical times in a woman’s life of pregnancy and the menopause – and their relation to heart health – is explored at the ESC. The defined field of gender-specific cardiology is becoming an increasingly important area of focus, experts say.
The interplay between the patient’s BMI, tumour size and cancer-specific proteins is of importance for the prognosis of breast cancer, a study from Sweden shows.
The language used by doctors when diagnosing female patients with polycystic ovary syndrome (PCOS) can negatively impact their wellbeing and how they view their condition, new research finds.
At the ECR 2022 congress in Vienna, Hologic went beyond just showcasing new systems for women’s health. Additional focus topics were the mitigation of the pandemic impact on screening programmes and the situation of women around the world without access to advanced diagnostic technologies – or even the most basic standards of healthcare.
Diagnostic imaging in women’s health advances: PET/CT might provide a more accurate imaging alternative to CT in ovarian cancer. T2*-weighted MR imaging in deep endometriosis detection also shows promise, but ultimately falls flat.
A new study has found that women’s health research remains disproportionately focused on the reproductive years, with few articles on the major causes of illness and death in women.
The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help women avoid unnecessary surgery.
Hologic and the Women's Tennis Association (WTA) kicked off a multi-year partnership, launching a joint vision to achieve greater wellness and equality for women.
Groundbreaking technologies have improved our ability to accurately diagnose breast cancer and reduce callbacks, focusing on compassionate care for patients as they move along their breast health journey.
Experts are leading a new initiative to help save the lives of thousands of women giving birth by Caesarean section in developing nations (LMIC).
Scientists have discovered a means of identifying the risk of breast and ovarian cancer by measuring epigenetic changes in cervical samples from over a thousand women.
Many women feel they are not being listened to about their health needs – and experience a lack of empathy around problems relating to menstruation, fertility, childbirth and menopause.
The COVID-19 pandemic has led to deficiencies and large inequalities in the care of mothers and newborns in Europe.
Gender-specific benefits of women should have a greater impact in interventional radiology (IR). But also, the field should see more women practicing the craft, two experts stressed at the most recent annual JFR meeting.
The breast imaging field plays a critical role in women’s health and wellbeing around the globe. Bringing together experts, leaders and innovators from across the breast imaging landscape, the 2021 European Society of Breast Imaging (EUSOBI) Congress comes at a crucial time and represents a pivotal opportunity for the industry as a whole. Taking place online from 4-28 October, 2021, the virtual…
Researchers at the Catharina Heart and Vascular Center, together with Eindhoven University of Technology, have developed a new measurement method to analyze the smallest capillaries of the heart by measuring blood flow and resistance. The new method to assess coronary microcirculation allows cardiologists to make a clearer diagnosis. Until recently, the tests used for this purpose were not…
Machine learning methods are being used to predict the health of the placenta from a 30-second MRI scan. Researchers hope the approach will offer an insight into the health of expectant mothers and unborn babies by detecting the early signs of dangerous conditions such as pre-eclampsia. Researchers from the School of Biomedical Engineering & Imaging Sciences at King’s College London (KCL)…
A study found that women who contract Covid-19 during pregnancy are at significantly higher risk of developing pre-eclampsia. In their study, researchers said their systematic review shows that women with SARS-CoV-2 infection during pregnancy had 62% higher odds of developing preeclampsia than those without the infection during pregnancy.
Hologic, Inc. shared the findings from its inaugural Hologic Global Women’s Health Index, the world’s most comprehensive, globally comparative survey about women’s health.
A study of more than 18 million pregnancies has shown a strong and graded relationship between women’s heart health and pregnancy outcomes. The research is published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC). The researchers examined the presence of four risk factors for cardiovascular disease in women prior to pregnancy: unhealthy…
Technologies based on artificial intelligence (AI) are considered the epitome of progress. However, the data AI algorithms use to draw their conclusions is outdated. It ignores the existence of biological sex and socio-cultural gender and their effects on individual health and disease states. German experts discussed the gender problem in healthcare AI at virtual.MEDICA 2020.
The contribution of Artificial intelligence (AI) has great potential in breast imaging efficiency, Professor Linda Moy MD told attendees at the 2021 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium this April. AI models for breast imaging have focused mainly on the diagnostic classification and detection of breast cancer.
A study showed that women are underrepresented in oncology, neurology, immunology, cardiology, hematology; whereas men underrepresented in trials related to mental health, musculoskeletal disease and trauma, and preventive care.
Women are missing out on appropriate cardiac care because guidelines and medications often fail to take into account gender and conditions that specifically affect the female population. Women are also underrepresented in clinical trials for new cardiac therapies.
Beckman Coulter announced the launch of an AMH test that uses a validated cut-off to aid in the assessment of poor ovarian response. This new assay helps clinicians predict poor ovarian response in those who plan to undergo controlled ovarian stimulation as part of an in vitro fertilisation (IVF) protocol.
